Condition
Soft Tissue Defects
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 1 (1)
P 4 (1)
Trial Status
Unknown2
Completed2
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07385313Phase 4RecruitingPrimary
Combined OFM and Vacuum-assisted Therapy for Expedited Regeneration Over Structures
NCT07151638Not ApplicableCompleted
First-in-Human Safety Study for Fractomer™ Biomatrix
NCT06885450CompletedPrimary
Perforator Pedicled V-Y Advanced Flaps for Coverage in the Lower Limbs
NCT05828771Not ApplicableUnknownPrimary
Outcomes and Clinical Applications of Thin Free Flaps for Soft Tissue Defects
NCT02590042Phase 1Unknown
Safety of Adipose-Derived Stem Cell Stromal Vascular Fraction
Showing all 5 trials